A Systematic Review and Meta-Analysis of the Association Between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2022 Nov 11

PMID 36358309

Authors

Anna Paola Capra

Alessio Ardizzone

Silvana Briuglia

Maria Angela La Rosa

Stefania Mondello

Michela Campolo

Emanuela Esposito

Affiliations

Soon will be listed here.

Abstract

This study evaluated the association between the H1299R factor V (FV) variant (rs1800595) and recurrent pregnancy loss (RPL). Pubmed (MEDLINE) and Embase (OVID) bibliographic databases were searched from the inception to 31 May 2022 to identify suitable articles according to PRISMA and MOOSE guidelines. We included observational studies, case-control studies, cross-sectional studies, and cohort studies reporting a numerical and well-distinguished Het or Hom status of the H1299R variant obtained through PCR or other biochemical techniques and comparing RPL patients with a healthy control group. The review protocol was registered at PROSPERO (CRD42022330077). Two authors independently screened studies, extracted data, and carried out the risk of bias assessment using the Newcastle Ottawa scale (NOS). A meta-analysis was performed with RevMan software Version 5.4 using an odds ratio (OR) with an M-H, random effect, and 95% CI. We included 13 clinical studies for a total of 1669 RPL patients and 1466 healthy women as a control group. H1299R variant was slightly associated with RPL albeit without significance (OR 1.18, 95% CI: 0.78-1.80, = 0.44). Subgroup analyses considering H1299R in heterozygosity (OR 1.13, 95% CI: 0.76-1.67, = 0.56) and in homozygosity (OR: 2.11, 95% CI: 0.74-6.01, = 0.16) revealed a similar trend. Lastly, we evaluated the association between H1299R and RPL based on the number of previous miscarriages (≥2 or ≥3). This comprehensive systematic review and meta-analysis sheds light on the specific influence of the H1299R variant in the F5 gene on RPL, constituting valid support for medical care during pregnancy and genetic counseling.

Citing Articles

The Impact of COVID-19 on Amputation and Mortality Rates in Patients with Acute Limb Ischemia: A Systematic Review and Meta-Analysis.

Crupi L, Ardizzone A, Calapai F, Scuderi S, Benedetto F, Esposito E Diseases. 2024; 12(4).

PMID: 38667532 PMC: 11048752. DOI: 10.3390/diseases12040074.

Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage.

Najjar A, Hassouna I, Srour M, Ibrahim H, Assi R, Abd El Latif H Thromb J. 2024; 22(1):20.

PMID: 38351006 PMC: 10865659. DOI: 10.1186/s12959-024-00587-7.

Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies.

Capra A, Ardizzone A, Crupi L, Calapai F, Campolo M, Cuzzocrea S Biomedicines. 2023; 11(8).

PMID: 37626685 PMC: 10452638. DOI: 10.3390/biomedicines11082189.

The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence.

Capra A, Ardizzone A, Panto G, Paterniti I, Campolo M, Crupi L Int J Mol Sci. 2023; 24(4).

PMID: 36834949 PMC: 9958638. DOI: 10.3390/ijms24043537.

References

Buchholz T, Thaler C . Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol. 2003; 50(1):20-32. DOI: 10.1034/j.1600-0897.2003.00049.x. View

Youssef A, Vermeulen N, Lashley E, Goddijn M, van der Hoorn M . Comparison and appraisal of (inter)national recurrent pregnancy loss guidelines. Reprod Biomed Online. 2019; 39(3):497-503. DOI: 10.1016/j.rbmo.2019.04.008. View

Peshkova A, Safiullina S, Evtugina N, Baras Y, Ataullakhanov F, Weisel J . Premorbid Hemostasis in Women with a History of Pregnancy Loss. Thromb Haemost. 2019; 119(12):1994-2004. DOI: 10.1055/s-0039-1696972. View

Ardizzone A, Capra A, Mondello S, Briuglia S, La Rosa M, Campolo M . H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol. Genes (Basel). 2022; 13(6). PMC: 9222435. DOI: 10.3390/genes13061019. View

Joksic I, Mikovic Z, Filimonovic D, Munjas J, Karadzov O, Egic A . Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population. J Med Biochem. 2020; 39(2):199-207. PMC: 7526018. DOI: 10.2478/jomb-2019-0028. View

Austin M, Hutter C, Zimmern R, Humphries S . Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004; 160(5):407-20. DOI: 10.1093/aje/kwh236. View

Barut M, Bozkurt M, Kahraman M, Yildirim E, Imirzalioglu N, Kubar A . Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues. Med Sci Monit. 2018; 24:4288-4294. PMC: 6045916. DOI: 10.12659/MSM.908832. View

Dilley A, Benito C, Hooper W, Austin H, Miller C, Cottrell S . Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fetal Neonatal Med. 2002; 11(3):176-82. DOI: 10.1080/jmf.11.3.176.182. View

Bender Atik R, Christiansen O, Elson J, Kolte A, Lewis S, Middeldorp S . ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2019; 2018(2):hoy004. PMC: 6276652. DOI: 10.1093/hropen/hoy004. View

10.

Izuhara M, Shinozawa K, Kitaori T, Katano K, Ozaki Y, Fukutake K . Genotyping analysis of the factor V Nara mutation, Hong Kong mutation, and 16 single-nucleotide polymorphisms, including the R2 haplotype, and the involvement of factor V activity in patients with recurrent miscarriage. Blood Coagul Fibrinolysis. 2016; 28(4):323-328. DOI: 10.1097/MBC.0000000000000598. View

11.

Hamedi B, Feulefack J, Khan A, Sergi C . Association between factor V Leiden mutation and recurrent pregnancy loss in the middle east countries: a Newcastle-Ottawa meta-analysis. Arch Gynecol Obstet. 2020; 302(2):345-354. DOI: 10.1007/s00404-020-05610-6. View

12.

Bigdeli R, Younesi M, Panahnejad E, Asgary V, Heidarzadeh S, Mazaheri H . Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the Iranian population. Syst Biol Reprod Med. 2018; 64(4):274-282. DOI: 10.1080/19396368.2018.1456576. View

13.

Sharma A, Bhakuni T, Ranjan R, Kumar R, Kishor K, Kamal V . Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population. J Thromb Thrombolysis. 2015; 39(4):481-8. DOI: 10.1007/s11239-015-1186-6. View

14.

Zaatari G, Otrock Z, Sabbagh A, Mahfouz R . Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology. 2006; 38(5):442-4. DOI: 10.1080/00313020600922934. View

15.

Sotiriadis A, Vartholomatos G, Pavlou M, Kolaitis N, Dova L, Stefos T . Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol. 2007; 57(2):133-41. DOI: 10.1111/j.1600-0897.2006.00454.x. View

16.

Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T . Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study. Thromb Haemost. 2006; 95(4):612-7. View

17.

Dissanayake V, Sirisena N, Weerasekera L, Gammulla C, Seneviratne H, Jayasekara R . Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. J Obstet Gynaecol Res. 2012; 38(9):1168-76. DOI: 10.1111/j.1447-0756.2012.01846.x. View

18.

Zonouzi A, Chaparzadeh N, Ghorbian S, Mehrzad Sadaghiani M, Farzadi L, Ghasemzadeh A . The association between thrombophilic gene mutations and recurrent pregnancy loss. J Assist Reprod Genet. 2013; 30(10):1353-9. PMC: 3824849. DOI: 10.1007/s10815-013-0071-5. View

19.

Sergi C, Al Jishi T, Walker M . Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Arch Gynecol Obstet. 2014; 291(3):671-9. DOI: 10.1007/s00404-014-3443-x. View

20.

Girardi G, Bremer A . Advancing research on recurrent pregnancy loss: Overcoming obstacles and opportunities for translation. Am J Reprod Immunol. 2021; 87(1):e13508. DOI: 10.1111/aji.13508. View